João Silva

发表

Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type a injection

P. Dinis, F. Cruz, A. Charrua, 2012, BMC Urology.

Intraprostatic botulinum toxin type A administration: evaluation of the effects on sexual function

F. Botelho, P. Dinis, F. Cruz, 2011, BJU international.

Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.

Rui Pinto, P. Dinis, F. Cruz, 2009, European urology.

Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment

R. Pinto, F. Botelho, P. Dinis, 2009, BMC urology.

Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement. Effect on prostate volume and micturition resumption.

Rui Pinto, P. Dinis, F. Cruz, 2008, European urology.

Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.

R. Pinto, P. Dinis, F. Cruz, 2011, The Journal of urology.

Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial.

M. Ribeiro, F. Cruz, A. Avelino, 2005, European urology.

Efficacy and safety of intra-trigonal injection of OnaBotulinum toxin A in patients with Bladder Pain Syndrome/Interstitial Cystitis. Interim analysis of an exploratory randomized, double blind, placebo-controlled trial

F. Cruz, A. Morgado, P. Pereira, 2016 .

Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A.

P. Dinis, F. Cruz, C. Cruz, 2014, Urology.

Mechanisms of prostate atrophy after glandular botulinum neurotoxin type a injection: an experimental study in the rat.

Rui Pinto, P. Dinis, F. Cruz, 2009, European Urology.